This is my archive

Use of Cognitive Screening among Older Adults Who Care for People with Dementia: A National Survey

Estimation of the value-based price of a blood test for Alzheimer’s disease pathology in primary and specialty care in the U.S

Measuring time saved in Alzheimer’s disease: What is a meaningful slowing of progression?

Usage patterns of cognitive assessments during Medicare’s Annual Wellness Visit: A national survey

Considerations for widespread implementation of blood‐based biomarkers of Alzheimer’s disease

Recommendations for clinical implementation of blood‐based biomarkers for Alzheimer’s disease

Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease

The age-specific comorbidity burden of mild cognitive impairment: a US claims database study

Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape

Expanding the use of brief cognitive assessments to detect suspected early-stage cognitive impairment in primary care